Final answer:
A practical nurse should hold the prescribed dose of dalteparin if the client shows signs of excessive bleeding, low platelet count, unusual bruising, bleeding from the gums or nose, or an allergic reaction. Regular assessments of blood counts and monitoring for bleeding or allergic symptoms are crucial when administering dalteparin.
Step-by-step explanation:
The practical nurse (PN) is preparing to administer dalteparin (Fragmin) subcutaneously to an immobile client who has been receiving the medication for 5 days. The finding that indicates that the PN should hold the prescribed dose might include signs of excessive bleeding, such as a low platelet count (thrombocytopenia), unusual bruising, or bleeding from the gums or nose. Additionally, if the client demonstrates signs of an allergic reaction, such as hives, difficulty breathing, or swelling of the face, lips, or tongue, the nurse should also withhold the medication and consult a healthcare provider.
When monitoring therapy with dalteparin, healthcare providers should perform regular assessments of blood counts including platelets, signs of bleeding or thrombosis, and potential allergic reactions. Finding any such signs necessitates an immediate hold on dalteparin administration and a reevaluation of the patient's treatment plan.